HB 2549 – Oklahoma
Status: Inactive / DeadYear Introduced: 2021
Link: http://www.oklegislature.gov/BillInfo.aspx?Bill=HB2549&Session=2200
An Act relating to pharmacy; defining terms;
providing for the substitution of an interchangeable
biological product for a prescribed biological product under certain conditions; requiring electronic notice of substitution; providing exceptions; directing State Board of Pharmacy to maintain link of all interchangeable biological
products; providing for codification; and providing an effective date.
Key Issues:
PHARMACEUTICALS
Biosimilar or Generic Competition
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found